ADMA Biologics (ADMA) Shares Jump 28% After-Hours: Here’s Why
ADMA Biologics shares surge after Q3 earnings growth as the company raises 2026 profit guidance.
Share
Why It Matters
ADMA made more money than expected this quarter. The company also said it will make even more money next year, which is why people got excited.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.